Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ:LMRIMedical - Devices
Healthcare
$14.01 +7.25%
+$0.84 today
- Market cap
- $1.35B
- Beta
- 2.18
- P/E (TTM)
- -34.3
- EPS (TTM)
- -$0.28
52W Low $6.45High $19.45
Volume 0.26M
Average 0.92M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$17.07M
FY 2025 · Annual
-58.1% YoYInvesting Cash Flow
-$20.96M
FY 2025 · Annual
Financing Cash Flow
$36.58M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Net Income | (122.23M) | (94.1M) | (47.1M) |
| Depreciation & Amortization | 72.14M | 57.16M | 55.39M |
| Deferred Income Tax | 611K | 9.75M | 8.08M |
| Stock-Based Compensation | 55.3M | 56.65M | 41.6M |
| Change in Working Capital | (4.14M) | (2.6M) | (44.35M) |
| Accounts Receivables | (15.3M) | (5.32M) | (14.01M) |
| Inventory | 0 | 0 | 0 |
| Accounts Payables | 4.76M | 2.95M | 14.42M |
| Other Working Capital | 6.4M | (225K) | (44.75M) |
| Other Non-Cash Items | 35.83M | 13.86M | 3.46M |
| Operating Cash Flow | 37.51M | 40.73M | 17.07M |
| Capital Expenditures | (24.01M) | (27.77M) | (23.48M) |
| Acquisitions (Net) | (5.65M) | 5.13M | 2.64M |
| Purchases of Investments | 0 | 0 | (123K) |
| Sales of Investments | 0 | 0 | 0 |
| Other Investing Activities | 0 | 361K | 0 |
| Investing Cash Flow | (29.66M) | (22.28M) | (20.96M) |
| Debt Repayment | (10.91M) | (12.67M) | (392.83M) |
| Common Stock Issued | 2.26M | 673K | 427.81M |
| Common Stock Repurchased | (118K) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 |
| Other Financing Activities | 0 | (506K) | 1.6M |
| Financing Cash Flow | (8.77M) | (12.5M) | 36.58M |
| Effect of Forex Changes | 0 | 0 | 0 |
| Net Change in Cash | (912K) | 5.95M | 32.7M |
| Free Cash Flow | 13.51M | 12.95M | (6.4M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$47.1M
+ D&A$55.4M
+ Stock-Based Comp$41.6M
+ Deferred Tax$8.1M
- Working Capital-$44.3M
+ Other Non-Cash$3.5M
= Operating Cash Flow$17.1M
- Capex-$23.5M
= Free Cash Flow-$6.4M
Analysis
FY2025 free cash flow is -$6.4M. FCF conversion is 13.6% of net income. Operating cash flow was $17.1M, with capex of -$23.5M. The largest bridge item is D&A at $55.4M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 12, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| SC 13G | SC 13G filing | Aug 14, 2026 | |
| 10-Q | Quarterly report | Aug 13, 2026 | |
| 8-K | Current report | Aug 12, 2026 |
Does LMRI generate free cash flow?
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) generated -$6.40M of free cash flow in fiscal 2025.
How much operating cash flow does LMRI produce?
Operating cash flow was $17.07M, before capital expenditures of $23.48M.
Continue the stock analysis
Jump to another research area for this company.